Lombard Medical, which offers innovative stent-grafts for highly angled endovascular aortic repair, raised $55 million by offering 5.0 million shares at $11. Lombard Medical plans to list on the NASDAQ under the symbol EVAR. Lombard Medical initially filed confidentially on 1/22/2014. Jefferies & Co. and Barclays acted as lead managers on the deal.
